(Q33331585)

English

Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer

scientific article

Statements

Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer (English)
1 February 2000

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit